Dear Colleagues,

Inflammation is a vital defense mechanism of the immune system for removing harmful stimuli and initiating the healing process. However, dysregulation of immune response and inflammation persistence due to inadequate resolution may lead to chronic inflammation with severe clinical symptoms having substantial socio-economic impact, high prevalence, and severe limitation of patient quality of life. Indeed, nanomedicines have attracted attention as suitable materials for diverse advanced medical applications for the last few decades. Among the studied nanomaterials, polymers, micelles, liposomes, and nanoparticles applicable for inflammation treatment belong to highly promising drug delivery systems, which allow for the controlled delivery and/or targeting of drugs, biomolecules, imaging, and contrast agents to the inflammation site.

This Special Issue of Pharmaceutics focuses on new strategies and approaches to nanomedicine-based systems intended for advanced anti-inflammatory therapy, which could help to solve issues dealing with passive and active targeting, resolution of inflammation, occurrence of side effects, and overcoming of biological barriers. We welcome articles concerning all aspects of nanomedicines intended for advanced therapy or diagnosis of inflammation. In particular, submissions on new materials, strategies, and synthetic approaches are welcome for this Special Issue.

Prof. Tomáš Etrych
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Inflammation
• Drug delivery
• Drug targeting
• Stimuli-sensitive behavior
• Resolution
• Theranostics
• Micelles
• Polymer carriers
• Overcoming of biological barriers